NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma
暂无分享,去创建一个
Robin L. Jones | J. Eary | E. Conrad | C. Yee | A. Jungbluth | S. Pollack | E. Loggers | B. Hoch | Erik A. Farrar | E. Rodler | D. J. Schneider | M. Bleakley